Search Results for: GNBT
From BioHealth Investor Biotechnology SHEFFIELD PHARMACTLS [SFPH.OB] +34.33% IMMTECH PHARM INC [IMM] +19.09% CYTORI THERAPEUTICS [CYTX] +9.96% VERNALIS PLC ADR [VNLS] +9.09% EMERGENT BIOSOLUTION...
Published:
From BioHealth Investor Biotechnology BIOSANTE PHARMA INC [BPA] +24.60% REPROS THERAPEUTICS [RPRX] +11.83% SUNESIS PHARMACEUTIC [SNSS] +11.72% POINT THERAPEUTICS [POTP] +8.91% IMMTECH PHARM INC [IMM]...
Published:
From BioHealth Investor Biotechnology INNCARDIO INC [ICDO.OB] +23.76% CYTOKINETICS [CYTK] +11.50% PIPEX PHARMACEUTICAL [PPXP.OB] +11.30% BIONOVO INC [BNVI.OB] +10.74% MEMORY PHARMACEUTICA [MEMY]...
Published:
Biotechnology ACADIA PHARMACEUTICA [ACAD] +103.44% NEURALSTEM INC [NRLS.OB] +10.51% CYTRX CP [CYTR] +10.19% ACORDA THERAPEUTICS [ACOR] +8.55% REXAHN PHARMACEUTICL [RXHN.OB] +7.69% Diagnostic...
Published:
(ALVR) Alvarion announces that the leading Taiwanese telecom service provider Chunghwa Telecom has selected its WiMAX solution(APC) Anadarko will record a $100 million charge on taxes in Algeria.(BA)...
Published:
by H.S. AyoubBioHealth Investor.com Biotechnology GENVEC INC [GNVC] +11.51% REXAHN PHARMACEUTICL [RXHN.OB] +10.71% 3SBIO INC [SSRX] +9.64% TERCICA INC [TRCA] +8.47% SEATTLE GENETICS I [SGEN] +8.14%...
Published:
by H.S. AyoubBioHealth Investor.com Sponsored: Find a Qualified Financial Advisor Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up...
Published:
(ABN) ABN AMRO is in an informal acquisition round of talks where Barclays would acquire the company.(ALXN) Alexion Pharma gets FDA marketing approval for Soliris.(ANPI) Angiotech Pharma announces...
Published:
GBT shares dipped on Friday after the company announced that it would be conducting a secondary offering. This offering comes on the heels of a key FDA approval.
Published:
Last Updated:
The SEC has announced that a former market analyst and TV news commentator has agreed to settle charges that he and his company fraudulently promoted a penny stock to investors.
Published:
Last Updated:
Syros Pharma and Global Blood Therapeutics shares were on the move on Wednesday after the companies announced a collaboration to develop and commercialize novel therapies for sickle cell disease and...
Published:
Global Blood Therapeutics shares shot up on Monday after the company announced that it received an update from the FDA in regards to its sickle cell disease treatment.
Published:
Last Updated:
Global Blood Therapeutics shares saw a handy gain in the premarket on Tuesday, despite the company pricing its secondary offering below its previous price level.
Published:
Last Updated:
Global Blood Therapeutics saw its shares pull back on Friday after the firm announced that it would be conducting a secondary offering.
Published:
Last Updated:
GBT shares jumped on Thursday after the company announced that the FDA has accepted for filing the company’s New Drug Application for voxelotor as a treatment of sickle cell disease.
Published: